Malaria vaccine provides 100% protection

malaria

 

Yesterday I wrote an article for the purpose of illustrating how fundamental research can, in a relatively short time frame (~10 years), go from fundamental research to proven, industrial scale applied technology.  These technological developments have the potential for great social benefit; assuming the developers are interested in those ends of course.  

Yesterday, in Nature News, it was reported that a Rockville, Maryland based company named Sanaria has developed a malaria vaccine that, in their limited trials, has conferred 100% protection against malaria infection.  That’s pretty remarkable considering the World Health Organization (WHO) had hoped for an 80% effective vaccine by 2025.

References:
Seder, R. A. et al. 2013, Science

 

Advertisements

About dylanlevac

I'm a recovering academic, who is transitioning out of research and pursuing opportunities in policy roles regulating plant biotechnology products.
This entry was posted in Uncategorized and tagged , , , , . Bookmark the permalink.

One Response to Malaria vaccine provides 100% protection

  1. Pingback: Malaria vaccine provides 100% protection | Life Science PhD Aventures

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s